News und Analysen
![Texas Senior Games Opens Registration for 2020 Games, Announces Humana as Top Sponsor](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Texas Senior Games Opens Registration for 2020 Games, Announces Humana as Top Sponsor
Registration for the 2020 Texas Senior Games, the multi-sport competition for seniors that will be held March 26 through April 5, 2020, in San Antonio, is now open. For the first time, leading
![Agilent Wins Multiple Innovation Awards](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Agilent Wins Multiple Innovation Awards
Agilent Technologies Inc. (NYSE: A) today announced that both The Analytical Scientist and The Medicine Maker have honored the Agilent InfinityLab LC/MSD iQ system with 2019 Innovation Awards.
![Cidara: NBC kassiert +136% plus Bonus!](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Cidara: NBC kassiert +136% plus Bonus!
Der No Brainer Club empfahl die Aktie von Cidara Therapeutics (WKN: A14R2R) am 26. September letzten Jahres „stark zu kaufen“. Seitdem steht ein zwischenzeitlicher Kursgewinn von +134% zu Buche
![EOS imaging Announces First Installation of EOSedge™ in North America](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
EOS imaging Announces First Installation of EOSedge™ in North America
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
![Aduro Biotech: Entspannte +50% für den NBC!](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Aduro Biotech: Entspannte +50% für den NBC!
Wieder konnten NBC-Mitglieder eine Aktie am Allzeittief aufkaufen, um in der Folgezeit entspannte "No Brainer-Prozente" einzufahren. Mit Aduro Biotech (WKN: A14Q7F) gab es nun gleich mehrfach die
![Family Physicians Group Names Cheri Greenfield La-Tour Market President](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Family Physicians Group Names Cheri Greenfield La-Tour Market President
Family Physicians Group, one of the Central Florida’s largest at-risk providers serving Medicare Advantage and Managed Medicaid HMO patients in Greater Orlando, has named Cheri Greenfield La-Tour
![Novavax: Coronavirus-Hype könnte Unternehmen retten, aber...](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Novavax: Coronavirus-Hype könnte Unternehmen retten, aber...
Bereits vorbörslich explodiert die Aktie von Novavax (WKN: A2PKMZ) heute um mehr als +60% und nähert sich damit wieder der runden 10-US-Dollar-Marke
Grund für den Kurssprung sind dabei
![Dexcom Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 13, 2020 at 4:30 p.m. Eastern Time](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Dexcom Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 13, 2020 at 4:30 p.m. Eastern Time
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2019 financial results after market close on Thursday, February 13, 2020. Management will hold a
![Dexcom Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 13, 2020 at 4:30 p.m. Eastern Time](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Dexcom Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 13, 2020 at 4:30 p.m. Eastern Time
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2019 financial results after market close on Thursday, February 13, 2020. Management will hold a
![Allegheny General Hospital Partners with Omnicell to Automate Sterile Compounding](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Allegheny General Hospital Partners with Omnicell to Automate Sterile Compounding
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Allegheny General Hospital
![Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Novocure (NASDAQ: NVCR) announced today that the State of Israel Ministry of Health has added Optune in combination with temozolomide to the Israeli medical services basket for the treatment of
![Otonomy: Tick, Tick, Boom! +120% sind erst der Anfang...](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Otonomy: Tick, Tick, Boom! +120% sind erst der Anfang...
Mit Otonomy (WKN: A119VZ) steht einer von etlichen NBC-Volltreffern vor der nächsten Zündstufe. Unsere Experten hatten den Verlauf exakt so angekündigt. Nun winken neue Kursdimensionen.
Als unsere
![Evotec: Management stapelt höher](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Evotec: Management stapelt höher
Tolle Neuigkeiten für Aktionäre: Evotec (WKN: 566480) hebt seine EBITDA-Prognose für 2019 an. Die Aktie reagiert merkwürdig.
Evotec verbessert seine Einschätzung nicht nur marginal, sondern
![Qiagen: Hier braut sich was zusammen!](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Qiagen: Hier braut sich was zusammen!
Die Aktie von Qiagen (WKN: A2DKCH) begab sich Ende letzten Jahres auf eine regelrechte Achterbahnfahrt. Dafür gab es auch gute Gründe, über die wir Sie hier auf sharedeals.de stets auf dem Laufenden
![Qiagen: Hier braut sich was zusammen!](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Qiagen: Hier braut sich was zusammen!
Die Aktie von Qiagen (WKN: A2DKCH) begab sich Ende letzten Jahres auf eine regelrechte Achterbahnfahrt. Dafür gab es auch gute Gründe, über die wir Sie hier auf sharedeals.de stets auf dem Laufenden
![Cannabis-Roundup: Canopy Growth & Aurora Cannabis](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Cannabis-Roundup: Canopy Growth & Aurora Cannabis
Investoren strömen wieder in den Sektor. In den letzten Tagen konnten die Aktien von Canopy Growth (WKN: A140QA), Aurora Cannabis (WKN: A12GS7) oder Tilray (WKN: A2JQSC) stark hinzugewinnen.
Das
![Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema
Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic
![Clinical trial demonstrated superior wound closure rates with PICO◊ compared to traditional NPWT in lower extremity ulcers1](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Clinical trial demonstrated superior wound closure rates with PICO◊ compared to traditional NPWT in lower extremity ulcers1
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the publication of a new randomized controlled trial (RCT) which demonstrated that the use of PICO Single
![Two Landmark Nature Publications use NanoString’s GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Two Landmark Nature Publications use NanoString’s GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the publication of two peer-reviewed studies using the GeoMx™
![EOS imaging Reports Its Full Year 2019 Sales](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
EOS imaging Reports Its Full Year 2019 Sales
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
![Clovis Oncology’s Rubraca® (rucaparib) Granted FDA Priority Review for Advanced Prostate Cancer](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Clovis Oncology’s Rubraca® (rucaparib) Granted FDA Priority Review for Advanced Prostate Cancer
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) for Rubraca® (rucaparib)
![Morphosys: Wer hätte das gedacht?](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Morphosys: Wer hätte das gedacht?
Morphosys-Aktien (WKN: 663200) verloren gestern im Handelsverlauf fast 23 Euro im Xetra-Handel. Ein so eklatanter Rutsch kam wohl auch für pessimistische Anleger überraschend.
Egal, was der
![Morphosys: Wer hätte das gedacht?](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Morphosys: Wer hätte das gedacht?
Morphosys-Aktien (WKN: 663200) verloren gestern im Handelsverlauf fast 23 Euro im Xetra-Handel. Ein so eklatanter Rutsch kam wohl auch für pessimistische Anleger überraschend.
Egal, was der
![Evotec: Es geht Schlag auf Schlag](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Evotec: Es geht Schlag auf Schlag
Ausnahmsweise ist die von Evotec (WKN: 566480) im Rahmen seiner heutigen Pressemitteilungen kommunizierte hochkarätige Forschungspartnerschaft nur eine (positive) Randnotiz. Diesmal geht es primär
![ICON Issues Financial Guidance for Full Year 2020](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
ICON Issues Financial Guidance for Full Year 2020
ICON plc (NASDAQ: ICLR), global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health